341 related articles for article (PubMed ID: 7628775)
1. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
Kolde HJ
Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
[No Abstract] [Full Text] [Related]
2. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
[TBL] [Abstract][Full Text] [Related]
3. Validity of the INR system for patients with liver impairment.
Denson KW; Reed SV; Haddon ME
Thromb Haemost; 1995 Jan; 73(1):162. PubMed ID: 7740488
[No Abstract] [Full Text] [Related]
4. A high-sensitivity thromboplastin reagent prepared from cultured human cells.
Valdes-Camin R; Callahan JB; Ebert RF
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):617-24. PubMed ID: 7841320
[TBL] [Abstract][Full Text] [Related]
5. Recombinant tissue factor as substitute for conventional thromboplastin in the prothrombin time test.
Tripodi A; Arbini A; Chantarangkul V; Mannucci PM
Thromb Haemost; 1992 Jan; 67(1):42-5. PubMed ID: 1615481
[TBL] [Abstract][Full Text] [Related]
6. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids.
Bader R; Mannucci PM; Tripodi A; Hirsh J; Keller F; Solleder EM; Hawkins P; Peng M; Pelzer H; Teijidor LM
Thromb Haemost; 1994 Mar; 71(3):292-9. PubMed ID: 8029792
[TBL] [Abstract][Full Text] [Related]
7. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
8. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
Loeliger EA; van Halem-Visser LP
Thromb Haemost; 1979 Dec; 42(4):1115-27. PubMed ID: 542924
[No Abstract] [Full Text] [Related]
9. Results of a multicenter study assessing the status of standardization of a recombinant thromboplastin for the control of oral anticoagulant therapy.
Tripodi A; Chantarangkul V; Braga M; Poller L; ten Cate JW; van den Besselaar AM; Mannucci PM
Thromb Haemost; 1994 Aug; 72(2):261-7. PubMed ID: 7831663
[TBL] [Abstract][Full Text] [Related]
10. Preparation of a standard brain thromboplastin.
Nour-Eldin F
New Istanbul Contrib Clin Sci; 1967; 9(3):120-32. PubMed ID: 16300157
[No Abstract] [Full Text] [Related]
11. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the quality of prothrombin time technique in the Basque Country].
Vacas M; Lafuente PJ; Aguirrebeitia MJ; Iriarte JA
Sangre (Barc); 1998 Feb; 43(1):41-5. PubMed ID: 9577180
[TBL] [Abstract][Full Text] [Related]
13. The response of Quick's prothrombin time test to oral anticoagulation. Influence of thromboplastin source and calcium chloride concentration.
van den Besselaar AM
Arch Pathol Lab Med; 1994 Feb; 118(2):145-9. PubMed ID: 8311653
[TBL] [Abstract][Full Text] [Related]
14. Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
Denson KW
Thromb Diath Haemorrh Suppl; 1968; 35():197-208. PubMed ID: 5761492
[No Abstract] [Full Text] [Related]
15. Current oral anticoagulant practice and its laboratory control in Thailand. III. Preparation of working human brain thromboplastin calibration against standard reference thromboplastin.
Talalak P
J Med Assoc Thai; 1979 Dec; 62(12):655-60. PubMed ID: 536654
[No Abstract] [Full Text] [Related]
16. Quality control and oral anticoagulation.
Preston FE
Thromb Haemost; 1995 Jul; 74(1):515-20. PubMed ID: 8578516
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of human blood coagulation elicited by thrombin.
Marciniak E
J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
[No Abstract] [Full Text] [Related]
18. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin.
van den Besselaar AM
Thromb Haemost; 2000 Sep; 84(3):410-2. PubMed ID: 11019963
[TBL] [Abstract][Full Text] [Related]
19. Present status of standardization in coagulation assays for control of oral anticoagulation.
Dati F; Becker U
Behring Inst Mitt; 1988 Apr; (82):309-24. PubMed ID: 3408455
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of prothrombin time reagent (Thromborel) and activated partial thromboplastin time reagent (Pathromtin) from human placenta with those from rabbit brain in laboratory practice (author's transl)].
Matsuoka M; Kobayashi I; Ito M; Sakuragawa N; Jimbo C; Hattori A; Watanabe T; Takahashi K; Hoshiyama M; Iizumi T; Sanada M; Ashizawa T; Takahashi H; Honda H; Shinada S
Rinsho Ketsueki; 1978 Jan; 19(1):22-30. PubMed ID: 564980
[No Abstract] [Full Text] [Related]
[Next] [New Search]
